Amark Preci is a capital markets business based in the US. Amark Preci shares (AMRK) are listed on the NASDAQ and all prices are listed in US Dollars. Amark Preci employs 343 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $32.00 |
|---|---|
| 52-week range | $20.41 - $44.60 |
| 50-day moving average | $35.71 |
| 200-day moving average | $34.07 |
| Wall St. target price | $51.17 |
| PE ratio | 5.5418 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $6.05 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $32 from 2022-06-29
| 1 week (2022-06-24) | -4.48% |
|---|---|
| 1 month (2022-06-01) | -56.21% |
| 3 months (2022-04-01) | -59.93% |
| 6 months (2021-12-31) | -47.63% |
| 1 year (2021-07-01) | -31.62% |
|---|---|
| 2 years (2020-07-01) | 68.51% |
| 3 years (2019-07-01) | 146.15% |
| 5 years (2017-06-30) | 95.28% |
Valuing Amark Preci stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amark Preci's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Amark Preci's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 6x. In other words, Amark Preci shares trade at around 6x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Amark Preci's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $208.7 million.
The EBITDA is a measure of a Amark Preci's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $8.2 billion |
|---|---|
| Operating margin TTM | 2.15% |
| Gross profit TTM | $210.2 million |
| Return on assets TTM | 8.58% |
| Return on equity TTM | 38.74% |
| Profit margin | 1.77% |
| Book value | $19.18 |
| Market capitalisation | $771.4 million |
TTM: trailing 12 months
Dividend payout ratio: 10.76% of net profits
Recently Amark Preci has paid out, on average, around 10.76% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Amark Preci shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Amark Preci's case, that would currently equate to about $0 per share.
While Amark Preci's payout ratio might seem low, this can signify that Amark Preci is investing more in its future growth.
Amark Preci's most recent dividend payout was on 23 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 16 September 2021 (the "ex-dividend date").
Amark Preci's shares were split on a 2:1 basis on 6 June 2022. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Amark Preci shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Amark Preci shares which in turn could have impacted Amark Preci's share price.
Over the last 12 months, Amark Preci's shares have ranged in value from as little as $20.4092 up to $44.595. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amark Preci's is -0.4383. This would suggest that Amark Preci's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Amark Preci has bucked the trend.
A-Mark Precious Metals, Inc. , together with its subsidiaries, operates as a precious metals trading company. It operates in three segments: Wholesale Sales & Ancillary Services, Direct-to-Consumer, and Secured Lending. The Wholesale Sales & Ancillary Services segment sells gold, silver, platinum, and palladium in the form of bars, plates, powders, wafers, grains, ingots, and coins. This segment also offers various ancillary services, including financing, storage, consignment, logistics, and various customized financial programs; and designs and produces minted silver products. The Direct-to-Consumer segment provides access to an array of gold, silver, copper, platinum, and palladium products through its websites and marketplaces. It operates five company-owned websites targeting specific niches within the precious metals retail market.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.